首页> 外文期刊>Japanese Journal of Cancer Research >In situ gene transfer and suicide gene therapy of gastric cancer induced by N-ethyl-N'-nitro-N-nitrosoguanidine in dogs.
【24h】

In situ gene transfer and suicide gene therapy of gastric cancer induced by N-ethyl-N'-nitro-N-nitrosoguanidine in dogs.

机译:N-乙基-N'-硝基-N-亚硝基胍诱导的犬胃癌原位基因转移和自杀基因治疗。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Gene therapy could potentially revolutionize the treatment of gastrointestinal (GI) tract cancer. The aim of this study was to establish a practical method of gene transfer which would be applicable to human gastric cancer. Retrovirus or/and adenovirus vectors carrying the lacZ marker gene were transferred in situ by needle through an endoscopic biopsy channel into primary gastric cancer in six male beagle dogs that had been treated with N-ethyl-N'-nitro-N-nitrosoguanidine (ENNG). In addition, an adenovirus vector carrying the herpes simplex virus thymidine kinase (Ad.CAGHSV-TK) gene was introduced in situ into cancer tissues in the stomach of three dogs, and the animals were treated with intravenous ganciclovir (GCV). Retrovirus-producing cells which expressed the lacZ gene were specifically localized to the injection site in the stomach. The lacZ gene was more widely transferred into the tumor by the adenovirus vector than by retrovirus-producing cells. Improvement of the needle used for gene transfer and the use of multiple injections per tumor led to more diffuse transfer of the vector into the tumor. The Ad.CAGlacZ gene was also transferred into regional lymph nodes of the stomach. Moderate to diffuse degeneration of the primary cancer tissues of the stomach was found after Ad.CAGHSV-TK/GCV gene therapy. Moreover, almost complete tissue degeneration was observed in the regional lymph nodes of the stomach. An adverse effect of HSV-TK/GCV gene therapy was acute hepatotoxicity, which was not found after Ad.CAGlacZ gene transfer, but was found after high-titer Ad.CAGHSV-TK gene transfer followed by GCV. These findings suggest that in situ gene transfer of a suicide gene followed by prodrug treatment may be applicable not only to primary tumors, but also to lymph node metastases of gastric cancer, though further study of both beneficial and adverse effects is required before clinical usage.
机译:基因治疗可能会彻底改变胃肠道癌的治疗方法。这项研究的目的是建立一种适用于人类胃癌的实用的基因转移方法。携带lacZ标记基因的逆转录病毒或/和腺病毒载体通过内窥镜活检通道经针原位转移到六只经N-乙基-N'-硝基-N-亚硝基胍(ENNG)治疗的雄性比格犬中,转移到原发性胃癌中)。另外,将携带单纯疱疹病毒胸苷激酶(Ad.CAGHSV-TK)基因的腺病毒载体原位引入三只狗的胃癌组织中,并用静脉更昔洛韦(GCV)治疗动物。表达lacZ基因的产生逆转录病毒的细胞特异性地定位在胃中的注射部位。 lacZ基因通过腺病毒载体比产生逆转录病毒的细胞更广泛地转移到肿瘤中。用于基因转移的针头的改进以及每个肿瘤多次注射的使用导致载体更扩散地转移到肿瘤中。 Ad.CAGlacZ基因也被转移到胃的局部淋巴结中。 Ad.CAGHSV-TK / GCV基因治疗后,发现胃中原发性癌组织出现中度弥漫性变性。此外,在胃的区域淋巴结中观察到几乎完全组织变性。 HSV-TK / GCV基因治疗的不良反应是急性肝毒性,在Ad.CAGlacZ基因转移后未发现,但在高滴度Ad.CAGHSV-TK基因转移后继之为GCV后发现。这些发现表明,自杀基因的原位基因转移后再进行前药治疗可能不仅适用于原发性肿瘤,而且还适用于胃癌的淋巴结转移,尽管在临床使用之前还需要进一步研究其有利和不利影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号